Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2010-05-18
2011-11-08
Robinson, Hope (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C424S425000, C424S426000
Reexamination Certificate
active
08053423
ABSTRACT:
The present invention is directed to a stabilized cross-linked hydrogel matrix comprising a first high molecular weight component and a second high molecular weight component that are covalently linked, and at least one stabilizing or enhancing agent, wherein the first high molecular weight component and the second high molecular weight component are each selected from the group consisting of polyglycans and polypeptides. This stabilized hydrogel matrix may be prepared as bioactive gels, pastes, slurries, cell attachment scaffolds for implantable medical devices, and casting or binding materials suitable for the construction of medical devices. The intrinsic bioactivity of the hydrogel matrix makes it useful as a gel or paste in multiple applications, including as a cell attachment scaffold that promotes wound healing around an implanted device, as gels and pastes for induction of localized vasculogenesis, wound healing, tissue repair, and regeneration, as a wound adhesive, and for tissue bulking.
REFERENCES:
patent: 4446316 (1984-05-01), Chazov et al.
patent: 4520821 (1985-06-01), Schmidt et al.
patent: 4614794 (1986-09-01), Easton et al.
patent: 4618490 (1986-10-01), De Marco
patent: 4772468 (1988-09-01), Pfirrmann
patent: 4863856 (1989-09-01), Dean, Jr. et al.
patent: 4883487 (1989-11-01), Yoshizato et al.
patent: 4895724 (1990-01-01), Cardinal et al.
patent: 4902295 (1990-02-01), Walthall et al.
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4957902 (1990-09-01), Grinnell
patent: 4997753 (1991-03-01), Dean, Jr. et al.
patent: 5099012 (1992-03-01), Wu et al.
patent: 5100783 (1992-03-01), Dean, Jr. et al.
patent: 5263983 (1993-11-01), Yoshizato et al.
patent: 5290558 (1994-03-01), O'Leary et al.
patent: 5303718 (1994-04-01), Krajicek
patent: 5350583 (1994-09-01), Yoshizato et al.
patent: 5376375 (1994-12-01), Rhee et al.
patent: 5457093 (1995-10-01), Cini et al.
patent: 5470911 (1995-11-01), Rhee et al.
patent: 5484601 (1996-01-01), O'Leary et al.
patent: 5514379 (1996-05-01), Weissleder et al.
patent: 5569468 (1996-10-01), Modi
patent: 5591709 (1997-01-01), Lindenbaum
patent: 5605938 (1997-02-01), Roufa et al.
patent: 5614205 (1997-03-01), Usala
patent: 5645591 (1997-07-01), Kuberasampath et al.
patent: 5705485 (1998-01-01), Cini et al.
patent: 5707877 (1998-01-01), Siiman et al.
patent: 5716404 (1998-02-01), Vacanti et al.
patent: 5718012 (1998-02-01), Cavallaro
patent: 5733337 (1998-03-01), Carr, Jr. et al.
patent: 5756715 (1998-05-01), Monte et al.
patent: 5783214 (1998-07-01), Royer
patent: 5800541 (1998-09-01), Rhee et al.
patent: 5824331 (1998-10-01), Usala
patent: 5830492 (1998-11-01), Usala
patent: 5834005 (1998-11-01), Usala
patent: 5866165 (1999-02-01), Liu et al.
patent: 5922339 (1999-07-01), Usala
patent: 5972385 (1999-10-01), Liu et al.
patent: 5993844 (1999-11-01), Abraham et al.
patent: 6011008 (2000-01-01), Domb et al.
patent: 6077916 (2000-06-01), Laurencin et al.
patent: 6132759 (2000-10-01), Schacht et al.
patent: 6165488 (2000-12-01), Tardy et al.
patent: 6197330 (2001-03-01), Rees et al.
patent: 6231881 (2001-05-01), Usala et al.
patent: 6261587 (2001-07-01), Usala
patent: 6303585 (2001-10-01), Spiro et al.
patent: 6352707 (2002-03-01), Usala
patent: 6391052 (2002-05-01), Buirge et al.
patent: 6458386 (2002-10-01), Schacht et al.
patent: 6833408 (2004-12-01), Sehl et al.
patent: 2002/0019516 (2002-02-01), Noff et al.
patent: 2002/0049281 (2002-04-01), Zhao et al.
patent: 0 213 908 (1987-03-01), None
patent: WO 92/19195 (1992-11-01), None
patent: WO 95/14037 (1995-05-01), None
patent: WO 97/41899 (1997-11-01), None
patent: WO 98/15299 (1998-04-01), None
patent: WO 00/02600 (2000-01-01), None
patent: WO 00/56251 (2000-09-01), None
patent: WO 01/74411 (2001-10-01), None
Aso, Y., et al., “Thermally Controlled Protein Release From Gelatin-Dextran Hydrogels,”Radiation Physics and Chemistry, 1999, pp. 179-183, vol. 55, Elsevier Science Ltd.
Ayhan, F., et al., “Optimization of Urease Immobilization onto Non-Porous HEMA Incorporated Poly(EGDMA) Microbeads and Estimation of Kinetic Parameters,”Bioresource Technology, 2002, pp. 131-140, vol. 81, Elsevier Science Ltd.
Bae, J.S., et al, “Synthesis and Characterization of Harparinized Polyurethanes Using Plasma Glow Discharge,”Biomaterials, 1999, pp. 529-537, vol. 20(6).
Bailey, A.J. and Light, N.D., “Intermolecular Cross-Linking in Fibrotic Collagen,”Ciba Found Symp., 1985, pp. 80-96, vol. 114.
Barié, N., et al., “Covalent Photolinker-Mediated Immobilization of an Intermediate Dextran Layer to Polymer-Coated Surfaces for Biosensing Applications,”Biosensors&Bioelectronics, 1998, pp. 855-860, vol. 13, Elsevier Science S.A.
Barker, H., et al, “Formaldehyde as a Pre-Treatment of Dermal Collagen Heterografts,”Biochimica et Biophysica Acta, 1980, pp. 589-597, vol. 632.
Ben Slimane, S., et al., Characteristics of Polyester Arterial Grafts Coated with Albumin, the Role and the Importance of the Crosslinking Chemicals,Eur. Surg. Res., 1988, pp. 18-28, vol. 20.
Bisson, I., et al., “Acrylic Acid Grafting and Collagen Immobilization on Poly(ethylene terephthalate) Surfaces for Adherence and Growth of Human Bladder and Smooth Muscle Cells,”Biomaterials, 2002, pp. 3149-3158, vol. 23, Elsevier Science Ltd.
Bos, G.W., et al., “Proliferation of Endothelial Cells on Surface-Immobilized Albumin-Heparin Conjugate Loaded with Basic Fibroblast Growth Factor,”J. Biomed. Mater. Res., 1999, pp. 330-340, vol. 44, John Wiley & Sons, Inc.
Boyan, B.D. et al., “Role of Material Surfaces in Regulating Bone and Cartilage Cell Response,”Biomaterials, 1996, pp. 137-146, vol. 17.
Boyce, S.T. and Hansborough, J.F., Biologic Attachment, Growth, and Differentiation of Cultured Human Epidermal Keratinocytes on a Graftable Collagen and chondroitin-6-sulfate substrate,Surgery, 1988, pp. 421-431, vol. 103.
Bubnis, W.A. and Ofner C.M. III, “The Determination of ε-Amino Groups in Soluble and Poorly Soluble Proteinaceous Materials by a Spectrophotometric Method Using Trinitrobezenesulfonic Acid,”Anal. Biochem., 1992, pp. 129-133, vol. 207.
Bulgarelli, E., et al, “Casein/Gelatin Beads: I. Cross-Linker Solution Composition Effect on Cross-Linking Degree,” 1999,Int. J. Pharm., 1999, pp. 175-182, vol. 190(2).
Butler, C., et al, “Regeneration of Neomucosa Using Cell-Seeded Collagen-GAG Matrices in Athymic Mice,”Annals of Plastic Surgery, 2002, pp. 298-304, vol. 48, Lippincott Williams & Wilkins, Inc.
Calero, P., et al., “Gelatinases in Soft Tissue Biomaterials. Analysis of Different Crosslinking Agents,”Biomaterials, 2002, pp. 3473-3478, vol. 23, Elsevier Science Ltd.
Cao, X. and Shoichet, M., “Photoimmobilization of Biomolecules within a 3-Dimensional Hydrogel Matrix,”J. Biomater. Sci. Polymer Edn., 2002, pp. 623-636, vol. 13(6).
Chandy, T., et al., “Use of Plasma Glow for Surface-Engineering Biomolecules to Enhance Bloodcompatibility of Dacron and PTFE Vascular Prosthesis,”Biomaterials, 2000, pp. 699-712, vol. 21, Elsevier Science Ltd.
Charulatha, V. and Rajaram, A., “Crosslinking Density and Resorption of Dimethyl Subermimidate-Treated Collagen,”J. Biomed. Mater. Res. 1997, pp. 478-486, vol. 15.
Charulatha, V. and Rajaram, A., “Dimethyl 3,3′-dithiobispropionimidate: A Novel Crosslinking Reagent for Collagen,”J. Biomed. Mater. Res., 2001, pp. 122-128, vol. 54.
Chegel, V., et al., “A Novel Aldehyde Dextran Sulfonate Matrix for Affinity Biosensors,”J. Biochem. Biophys. Methods, 2002, pp. 201-216, vol. 50, Elsevier Science B.V.
Chen, T., et al., “In Vitro Protein-Polysaccharide Conjugation: Tyrosinase-Catalyzed Conjugation of Gelatin and Chitosan,”Biopolymers, 2002, pp. 292-302, vol. 64, Wiley Periodicals, Inc.
Chevolot, Y., et al, “Immobilisation on Polystyrene of Diazirine Derivatives of Mono- and Disaccharides: Biological Activities of Modified Surfaces,
Hill Ronald Stewart
Klann Richard Chris
Lamberti Francis V.
Encelle, Inc.
Robinson Hope
Womble Carlyle Sandridge & Rice LLP
LandOfFree
Method of preparing cross-linked bioactive hydrogel matrices does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing cross-linked bioactive hydrogel matrices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing cross-linked bioactive hydrogel matrices will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291500